OmniBRx Biotechnologies Profile Photo

OmniBRx Biotechnologies

(OMNIBRX BIOTECHNOLOGIES PRIVATE LIMITED)

18 Published Patents

Founded in 2016

About OmniBRx Biotechnologies

Omnibrx Biotechnologies is a manufacturer of single-use bioreactors. The startup’s CellBRx technology supports the production of vaccines, recombinant therapeutics, and stem cells. PerfBRx enables high cell-density perfusion cell culture and is used in applications related to vaccines and cell therapies.

Key Founders and Directors of OmniBRx Biotechnologies

Key Focus Areas of OmniBRx Biotechnologies

Bioreactor Manufacturing +2 more focus areas

Angel Investors of OmniBRx Biotechnologies

+1 more angel

Frequently Asked Questions (FAQ)

When was OmniBRx Biotechnologies founded?

OmniBRx Biotechnologies was founded in the year 2016.

What is the legal name of OmniBRx Biotechnologies?

The legal name of OmniBRx Biotechnologies is Omnibrx Biotechnologies Private Limited.

Who are the founders of OmniBRx Biotechnologies?

OmniBRx Biotechnologies is founded by Ravindra Patel

Who all are Angel Investors of OmniBRx Biotechnologies?

OmniBRx Biotechnologies is funded by Angel Investors like Arun Aggarwal and 1 other.

Which Incubators & Accelerators supported OmniBRx Biotechnologies?

OmniBRx Biotechnologies is supported by Incubators & Accelerators like Centre For Advancing And Launching Enterprises (Cradle), Gandhinagar and 1 other.

What are the focus areas of OmniBRx Biotechnologies?

The key focus areas of OmniBRx Biotechnologies are Bioreactor Manufacturing and 2 others.

Who are OmniBRx Biotechnologies's competitors?

Possible competitors of OmniBRx Biotechnologies may include Apac Biotech Private Limited, Affigenix, Ameliorate Biotech and 7 others.

Get Access to Complete Information

Signup Now

YNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly suggest edits